CIRCIO HOLDING ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 NOK | +3.57% |
|
-46.10% | -59.72% |
| Apr. 17 | Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform | MT |
| Apr. 17 | Circio to Raise Up to NOK60 Million via Rights Issue | MT |
Chart calendar Circio Holding ASA
ac7f92acea7f7e98b5029f614d.uVDgs6iGznIxHzfHflqYlkc9SIA-hIwZm-UC-36AgtI.9Aa1ipzWiDxeMk2LEh_09xgPMu9v6b143YhLiS3N5oTXF5SF4NGMHnpqVA~548a22efa36a2aef324c5d2a01557e65
Upcoming events on Circio Holding ASA
Past events on Circio Holding ASA
| 2024-04-17 02:00 am | Business Update Call |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-02-28 05:50 am | European Life Sciences CEO Forum |
| 2024-02-15 01:00 am | Q4 2023 Earnings Release |
| 2024-02-14 12:00 am | Redeye Regenerative Medicine/Cell Therapy Event |
| 2024-01-24 05:27 am | Redeye Fight Cancer Meeting |
| 2024-01-22 07:15 am | BioSeed Conference |
| 2024-01-07 | Biotech Showcase |
| 2023-12-13 | DNBs Nordic Healthcare Conference |
| 2023-11-29 10:00 am | Circular RNA R&D Webinar - Key Opinion Leader |
| 2023-11-23 12:00 am | Redeye Life Science Day |
| 2023-11-09 01:00 am | Q3 2023 Earnings Release |
| 2023-10-25 11:00 am | European Society of Gene and Cell Therapy Conference - Poster Number: P803 |
| 2023-10-11 04:00 am | Business Update Call |
| 2023-09-27 03:00 am | Extraordinary Shareholders Meeting |
| 2023-09-25 02:00 pm | International Adenovirus Meeting - Abstract No:16 |
| 2023-09-19 04:00 am | Business Update Call |
| 2023-08-24 04:00 am | Q2 2023 Earnings Call |
| 2023-08-24 01:00 am | Q2 2023 Earnings Release |
| 2023-06-15 04:00 am | Business Update Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 0,03 0,00 - | 2,25 0,00 - | 0,62 4,77 -86.91% | 0,00 0,00 - | 10,0 0,00 - | 0,00 |
|
EBITDA Million NOK | Released Forecast Spread | -146 -141 -3.18% | -146 -138 -5.73% | -100 -104 4.14% | -94,3 -112 15.51% | -101 -110 8.55% | -102 |
|
EBIT Million NOK | Released Forecast Spread | -146 -141 -3.29% | -150 -139 -8.49% | -104 -106 2.06% | -95,6 -114 15.85% | -102 -111 8.02% | -104 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -147 -142 -3.46% | -148 -140 -5.72% | -108 -107 -1.77% | -98,0 -116 15.22% | -103 -112 8.76% | -104 |
|
Net income Million NOK | Released Forecast Spread | -147 -142 -3.23% | -148 -140 -5.57% | -108 -106 -1.61% | -98,0 -116 15.26% | -103 -112 8.79% | -102 |
|
EPS NOK | Released Forecast Spread | -83,7 -81,0 -3.33% | -72,9 -73,6 0.93% | -42,0 -40,2 -4.48% | -33,0 -40,1 17.62% | -16,2 -17,8 9.2% | -10,6 |
| Announcement Date | 14/02/19 | 11/03/20 | 18/02/21 | 17/02/22 | 16/02/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2020 S1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 0,01 0,01 20% | 0,59 0,00 - | 0,00 0,10 - | 0,00 0,20 - | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 10,0 0,00 - | 0,00 | 0,00 |
|
EBITDA Million NOK | Released Forecast Spread | -82,2 -79,7 -3.11% | -57,0 -62,8 9.29% | -24,2 -27,5 11.86% | -45,5 -47,9 4.98% | -22,2 -25,6 13.1% | -25,2 -24,0 -4.92% | -28,7 -27,5 -4.47% | -30,4 -25,0 -21.5% | -19,9 -27,0 26.14% | -21,8 -29,0 24.8% | -32,5 | -32,5 |
|
EBIT Million NOK | Released Forecast Spread | -59,0 -62,8 6.07% | -24,5 -30,0 18.24% | -22,5 -25,0 9.84% | -25,5 -24,0 -6.35% | -29,1 -27,5 -5.72% | -30,7 -25,3 -21.35% | -20,3 -25,8 21.27% | -22,2 -25,8 13.84% | -32,5 | -32,5 | ||
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -86,7 -82,6 -4.93% | -59,4 -58,5 -1.47% | -25,6 -28,2 9.22% | -48,1 -48,8 1.53% | -23,3 -26,1 10.48% | -26,7 -24,0 -11.05% | -30,4 -27,5 -10.72% | -29,2 -25,3 -15.27% | -20,7 -25,8 19.48% | -22,2 -25,8 13.77% | -32,5 | -32,5 |
|
Net income Million NOK | Released Forecast Spread | -86,5 -82,4 -4.98% | -59,2 -58,4 -1.39% | -25,5 -28,2 9.28% | -48,0 -48,8 1.6% | -23,3 -26,1 10.52% | -26,6 -24,0 -11% | -30,4 -27,5 -10.68% | -29,2 -25,3 -15.23% | -20,7 -25,8 19.52% | -22,2 -25,8 13.81% | -32,5 | -32,5 |
|
EPS NOK | Released Forecast Spread | -44,7 -42,6 -4.93% | -24,0 -23,7 -1.27% | -9,00 -9,60 6.25% | -16,5 -16,8 1.79% | -8,10 -8,85 8.47% | -8,40 -8,40 0% | -4,80 -4,38 -9.57% | -4,50 -4,03 -11.62% | -3,30 -4,35 24.14% | -3,60 -4,67 22.89% | -5,18 | -5,18 |
| Announcement Date | 22/08/19 | 20/08/20 | 18/08/21 | 18/08/21 | 04/11/21 | 17/02/22 | 12/05/22 | 18/08/22 | 03/11/22 | 16/02/23 | - | - |
More events
Past sector events for Circio Holding ASA
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRVX Stock
- Calendar Circio Holding ASA
